Devaluing energy-dense foods for cancer-control for Cancer

University of Oregon, Lewis Integrative Sciences Building, Eugene, OR
Cancer+1 More ConditionsDevaluing energy-dense foods for cancer-control - Behavioral
Eligibility
18 - 60
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether two different programs can help people reduce their intake of energy-dense foods and lose weight, with the goal of reducing their risk of cancer.

Eligible Conditions
  • Cancer
  • Overweight and Obesity

Treatment Effectiveness

Study Objectives

2 Primary · 19 Secondary · Reporting Duration: baseline, 1 month

baseline, 1 month
Change from Baseline Behavioral Response Biases Toward and Away from Cancer Risk and Healthy Foods at 1 month, Behavioral marker, Task 1
Change from Baseline Behavioral Response Biases Toward and Away from Cancer Risk and Healthy Foods at 1 month, Behavioral marker, Task 2
Change from Baseline Behavioral Response Biases Toward and Away from Cancer Risk and Healthy Foods at 1 month, Neural marker, Task 1
Change from Baseline Behavioral Response Biases Toward and Away from Cancer Risk and Healthy Foods at 1 month, Neural marker, Task 2
Change from Baseline Body Fat Percent at 1 month
Change from Baseline Body Mass Index at 1 month
Change from Baseline Cancer Risk and Healthy Food Craving and Valuation at 1 month, Self-report Questionnaire 2
Change from Baseline Cognitive Reappraisal of Food at 1 month, Behavioral marker
Change from Baseline Cognitive Reappraisal of Food at 1 month, Neural marker
Change from Baseline Cognitive Tendencies at 1 month, Self-Report Questionnaire 1
Change from Baseline Cognitive Tendencies at 1 month, Self-Report Questionnaire 2
Change from Baseline Food Approach and Avoidance Behavior at 1 month, Self-Report Questionnaire 2
Change from Baseline Food Approach and Avoidance Behavior at 1 month, Self-Report Questionnaire 3
Change from Baseline Food Intake at 1 month using dietary assessment tool
Change from Baseline Food Intake at 1 month, Self-Report Questionnaire
Change from Baseline Food-related Habitual Behavior at 1 month, Self-report Questionnaire 1
Change from Baseline Habitual Response to Food at 1 month, Behavioral marker
Change from Baseline Habitual Response to Food at 1 month, Neural marker
Change from Baseline Valuation of Subjective Value of Various Foods at 1 month, Behavioral marker
Change from Baseline Valuation of Subjective Value of Various Foods at 1 month, Neural marker
Hip structure

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

3 Treatment Groups

Generic Response Training
1 of 3
Behavioral Response Training
1 of 3
Cognitive Reappraisal Training
1 of 3

Active Control

Experimental Treatment

253 Total Participants · 3 Treatment Groups

Primary Treatment: Devaluing energy-dense foods for cancer-control · No Placebo Group · N/A

Behavioral Response Training
Behavioral
Experimental Group · 1 Intervention: Devaluing energy-dense foods for cancer-control · Intervention Types: Behavioral
Cognitive Reappraisal Training
Behavioral
Experimental Group · 1 Intervention: Devaluing energy-dense foods for cancer-control · Intervention Types: Behavioral
Generic Response Training
Behavioral
ActiveComparator Group · 1 Intervention: Devaluing energy-dense foods for cancer-control · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 1 month

Who is running the clinical trial?

University of OregonLead Sponsor
71 Previous Clinical Trials
39,143 Total Patients Enrolled
Elliot Berkman, Ph.D.Principal InvestigatorUniversity of Oregon

Eligibility Criteria

Age 18 - 60 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

What are the main goals of this clinical investigation?

"This clinical trial seeks to assess changes in food intake, behavioral responses towards cancer risk and healthy foods, cognitive tendencies, as well as waist-to-hip ratio across a one-month baseline. Secondary outcomes encompass performance on an inhibitory control task with personal risk cues, the need for cognition self-report questionnaire (with scores ranging from -4 to +4), and an index of body morphology based on external measurements." - Anonymous Online Contributor

Unverified Answer

How many participants are currently enrolled in this research project?

"Affirmative. According to clinicaltrials.gov, this medical trial has been open since May 1st 2018 and is actively recruiting patients. An estimated 300 subjects are required at a single site of study." - Anonymous Online Contributor

Unverified Answer

Is there an ongoing opportunity to join this medical research?

"Per clinicaltrials.gov, this medical trial is actively recruiting; the post was first launched on May 1st 2018 and most recently revised on September 7th 2022." - Anonymous Online Contributor

Unverified Answer

Does the trial include individuals of legal age?

"The criteria for joining this clinical trial stipulates that enrollees must be between 18 and 60 years old. Separately, 115 trials are recruiting minors while 639 studies accept participants over the age of 65." - Anonymous Online Contributor

Unverified Answer

What prerequisites must an individual meet to be eligible for this trial?

"This study is recruiting 300 participants between 18 and 60 years of age who have malignancies. The primary prerequisite for eligibility is falling within the overweight to obese range (BMI 25-35)." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.